C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis

Background. No previous randomized controlled studies have been reported examining de novo, once every 4 weeks (Q4W) administration of erythropoiesis-stimulating agents in chronic kidney disease (CKD) patients. We report results from a randomized multinational study that compared continuous erythrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Roger, Simon D., Locatelli, Francesco, Woitas, Rainer P., Laville, Maurice, Tobe, Sheldon W., Provenzano, Robert, Golper, Thomas A., Ruangkanchanasetr, Prajej, Lee, Ho Yung, Wu, Kwan-Dun, Nowicki, Michal, Ladanyi, Agnes, Martínez-Castelao, Alberto, Beyer, Ulrich, Dougherty, Frank C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
II. Scientific Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224113/
https://www.ncbi.nlm.nih.gov/pubmed/21505096
http://dx.doi.org/10.1093/ndt/gfr160

Ejemplares similares

Ejemplares similares